Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 3—June 1999
Synopsis

Emergence of a Unique Group of Necrotizing Mycobacterial Diseases

Karen M. Dobos*†, Frederick D. Quinn†, David A. Ashford†, C. Robert Horsburgh*, and C. Harold King*Comments to Author 
Author affiliations: *Emory University School of Medicine, Atlanta, Georgia, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 1

Early-(A) and late- stage (B) disease histopatho- logic sections of the dermis stained for acid-fast bacilli (AFB) from a patient with a Mycobacterium ulcerans infection. In A, arrows indicate necrosis of adipose tissue distant from the location of AFB, and in B, the arrow indicates predominance of extracellular bacilli and microcolonies. Patients' samples were obtained from the study conducted in Côte d'Ivoire (12). (Photos courtesy of National Center for Infectious Diseases, CDC, Atlanta, Geor

Figure 1. Early-(A) and late- stage (B) disease histopatho- logic sections of the dermis stained for acid-fast bacilli (AFB) from a patient with a Mycobacterium ulcerans infection. In A, arrows indicate necrosis of adipose tissue distant from the location of AFB, and in B, the arrow indicates predominance of extracellular bacilli and microcolonies. Patients' samples were obtained from the study conducted in Côte d'Ivoire (12). (Photos courtesy of National Center for Infectious Diseases, CDC, Atlanta, Georgia.)

Main Article

References
  1. Murray  CJ, Styblo  K, Rouillon  A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis. 1990;65:6–24.PubMedGoogle Scholar
  2. Raviglione  MC, Narain  JP, Kochi  A. HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment. Bull World Health Organ. 1992;70:515.PubMedGoogle Scholar
  3. Falkinham  JO. Epidemiology of infection by nontuberculosis mycobacteria. Clin Microbiol Rev. 1996;9:177–215.PubMedGoogle Scholar
  4. Horsburgh  CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 1996;324:1332–8.
  5. Horsburgh  CR Jr. Epidemiology of diseases caused by nontuberculosis mycobacteria. Semin Respir Infect. 1996;11:244–54.PubMedGoogle Scholar
  6. World Health Organization targets untreatable ulcer: report from the first international conference on Buruli ulcer control and research. Yamousoukro (Côte d'Ivoire): Inter Press Service; 1998 Jul 31.
  7. MacCallum  P, Tolhurst  JC, Buckle  G, Sissons  HA. A new mycobacterial infection in man. J Pathol Bacteriol. 1948;60:93–122. DOIPubMedGoogle Scholar
  8. Dodge  OG, Lunn  HF. Buruli ulcer: a mycobacterial skin ulcer in a Uganda child. J Trop Med Hyg. 1962;65:139–42.PubMedGoogle Scholar
  9. Horsburgh  CR Jr, Meyers  WM. Buruli ulcer. In: Horsburgh CR Jr, Nelson AM, editors. Pathology of emerging infections. Washington: American Society for Microbiology Press; 1997. p. 119-26.
  10. Dawson  JF, Allen  GE. Ulcer due to Mycobacterium ulcerans in Northern Ireland. Clin Exp Dermatol. 1985;10:572–6. DOIPubMedGoogle Scholar
  11. Kozin  SH, Bishop  AT. Atypical mycobacterial infections of the upper extremity. J Hand Surg. 1994;19:480–7. DOIGoogle Scholar
  12. Marston  BJ, Diallo  MO, Horsburgh  CR Jr, Diomande  I, Saki  MZ, Kanga  JM, Emergence of Buruli ulcer disease in the Daloa region of Côte d'Ivoire. Am J Trop Med Hyg. 1995;52:219–24.PubMedGoogle Scholar
  13. Johnson  PDR, Veitch  MG, Leslie  DE, Flood  PE, Hayman  JA. The emergence of Mycobacterium ulcerans infection near Melbourne. Med J Aust. 1996;164:76–8.PubMedGoogle Scholar
  14. Feldman  RA, Hershfield  E. Mycobacterial skin infection by an unidentified species. A report of 29 patients. Ann Intern Med. 1974;80:445–52.PubMedGoogle Scholar
  15. Sompolinsky  D, Lagziel  A, Naveh  D, Yankilevitz  T. Mycobacterium haemophilum sp. nov, a new pathogen of humans. Int J Syst Bacteriol. 1978;28:67–75. DOIGoogle Scholar
  16. Gouby  A, Branger  B, Oules  R, Ramuz  M. Two cases of Mycobacterium haemophilum infection in a renal dialysis unit. J Med Microbiol. 1988;25:299–300. DOIPubMedGoogle Scholar
  17. O'Brien  RJ, Geiter  LJ, Snider  DE. The epidemiology of nontuberculous mycobacterial diseases in the United States. Am Rev Respir Dis. 1987;135:1007–14.PubMedGoogle Scholar
  18. Bean  NH, Martin  SM, Bradford  H Jr. PHLIS: an electronic system for reporting public health data from remote sites. Public Health Briefs. 1992;82:1273–6.
  19. Saubolle  MA, Kiehn  TE, White  MH, Rudinsky  MF, Armstrong  D. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev. 1996;9:435–47.PubMedGoogle Scholar
  20. Kiehn  TE, White  M. Mycobacterium haemophilum: an emerging pathogen. Eur J Clin Microbiol Infect Dis. 1994;13:925–31. DOIPubMedGoogle Scholar
  21. Armstrong  KL, James  RW, Dawson  DJ, Francis  PW, Masters  B. Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. J Pediatr. 1992;121:202–5. DOIPubMedGoogle Scholar
  22. Hayman  J. Clinical features of Mycobacterium ulcerans infection. Aust J Dermatol. 1985;26:67–73. DOIGoogle Scholar
  23. Hayman  J. Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection. J Clin Pathol. 1993;46:5–9. DOIPubMedGoogle Scholar
  24. Huminer  D, Pitlik  SD, Block  C, Kaufman  L, Amit  S, Rosenfeld  JB. Aquarium-borne Mycobacterium marinum skin infection. Report of a case and review of the literature. Arch Dermatol. 1986;122:698–703. DOIPubMedGoogle Scholar
  25. Hanau  LH, Leaf  A, Soeiro  R, Weiss  LM, Pollack  SS. Mycobacterium marinum infection in a patient with the acquired immunodeficiency syndrome. infection in a patient with the acquired immunodeficiency syndrome. Cutis. 1994;54:103–5.PubMedGoogle Scholar
  26. Tchornobay  AM, Claudy  A, Perrot  JL, Levigne  M, Denis  M. Fatal disseminated mycobacterium marinum infection. Int J Dermatol. 1992;31:286–7. DOIPubMedGoogle Scholar
  27. Parent  LJ, Salam  MM, Appelbaum  PC, Dossett  JH. Disseminated Mycobacterium marinum infection and bacteremia in a child with severe combined immunodeficiency. Clin Infect Dis. 1995;21:1325–7.PubMedGoogle Scholar
  28. Straus  WL, Ostroff  SM, Jernigan  DB, Kiehn  TE, Sordillo  EM, Armstrong  D, Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med. 1994;120:118–25.PubMedGoogle Scholar
  29. Sompolinsky  D, Lagziel  A, Rosenberg  I. Further studies of a new pathogenic mycobacterium (M. haemophilum sp. nov.). Can J Microbiol. 1979;25:217–26. DOIPubMedGoogle Scholar
  30. Fischer  LJ, Quinn  FD, White  EH, King  CH. Intracellular growth and cytotoxicity of Mycobacterium haemophilum in a human epithelial cell line (Hec-1-B). Infect Immun. 1996;64:269–76.PubMedGoogle Scholar
  31. Ramakrishnan  L, Falkow  S. Mycobacterium marinum persists in cultured mammalian cells in a temperature-restricted fashion. Infect Immun. 1994;62:3222–9.PubMedGoogle Scholar
  32. Mor  N. Multiplication of Mycobacterium marinum within phagolysosomes of murine macrophages. Infect Immun. 1985;48:850–2.PubMedGoogle Scholar
  33. Pimsler  M, Sponsler  TA, Meyers  WM. Immunosuppressive properties of the soluble toxin from Mycobacterium ulcerans. J Infect Dis. 1988;157:577–80.PubMedGoogle Scholar
  34. Rastogi  N, Blom-Potar  MC, David  HL. Comparative intracellular growth of difficult-to-grow and other mycobacteria in a macrophage cell line. Acta Leprol. 1989;7:156–9.PubMedGoogle Scholar
  35. Read  RG, Heggie  CM, Meyers  WM, Connor  DH. Cytotoxic activity of Mycobacterium ulcerans. Infect Immun. 1974;9:1114–22.PubMedGoogle Scholar
  36. Krieg  RE, Hockmeyer  WT, Connor  DH. Toxin of Mycobacterium ulcerans: production and effects in guinea pig skin. Arch Dermatol. 1974;110:783–8. DOIPubMedGoogle Scholar
  37. Hockmeyer  WT, Krieg  RE, Reich  M, Johnson  RD. Further characterization of Mycobacterium ulcerans toxin. Infect Immun. 1978;21:124–8.PubMedGoogle Scholar
  38. George  KM, Barker  LP, Welty  DM, Small  PLC. Partial purification and characterization of biological effects of a lipid toxin produced by M. ulcerans. Infect Immun. 1998;66:587–93.PubMedGoogle Scholar
  39. Abbott  MR, Smith  DD. The pathogenic effects of Mycobacterium haemophilum in immunosuppressed albino mice. J Med Microbiol. 1980;13:535–40. DOIPubMedGoogle Scholar
  40. Clark  HF, Shepard  CC. Effect of environmental temperatures on infection with Mycobacterium marinum (balnei) of mice and a number of poikilothermic species. J Bacteriol. 1986;86:1057–69.
  41. Ramakrishnan  L, Valdivia  RH, Mckerrow  JH, Falkow  S. Mycobacterium marinum causes both long-term subclinical infection and acute disease in the leopard frog (Rana pipiens). Infect Immun. 1997;65:767–73.PubMedGoogle Scholar
  42. Mitchell  PJ, Jerrett  IV, Slee  KJ. Skin ulcers caused by Mycobacterium ulcerans in koalas near Bairnsdale, Australia. Pathology. 1984;16:256–60. DOIPubMedGoogle Scholar
  43. Barker  DJP. The distribution of Buruli disease in Uganda. Trans R Soc Trop Med Hyg. 1972;66:867–74. DOIPubMedGoogle Scholar
  44. Ross  BC, Johnson  PD, Oppedisano  F, Marino  L, Sievers  A, Stinear  T, Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease. Appl Environ Microbiol. 1997;63:4135–8.PubMedGoogle Scholar
  45. Roberts  B, Hirst  R. Immunomagnetic separation and PCR for detection of Mycobacterium ulcerans. J Clin Microbiol. 1997;35:2709–11.PubMedGoogle Scholar
  46. Ameh  EA, Dogo  PM, Ahmed  A, Maitama  HY, Esangbedo  AE, Nmadu  PT. Mycobacterium ulcerans skin infection in a patient with HIV infection: is this incidental? Trop Doct. 1997;27:59.PubMedGoogle Scholar
  47. Delaporte  E, Savage  C, Alfandari  S, Piette  F, Leclerc  H, Bergoend  H. Buruli ulcer in a Zairian woman with HIV infection. Ann Dermatol Venereol. 1994;121:557–60.PubMedGoogle Scholar
  48. Allen  S. Buruli ulcer and HIV infection. Int J Dermatol. 1992;31:744–5. DOIPubMedGoogle Scholar
  49. Portaels  F, Dawson  DJ, Larsson  L, Rigouts  L. Biochemical properties and fatty acid composition of Mycobacterium haemophilum: study of 16 isolates from Australian patients. J Clin Microbiol. 1993;31:26–30.PubMedGoogle Scholar
  50. Collins  CH, Grange  JM, Yates  MD. A review: mycobacteria in water. J Appl Bacteriol. 1984;57:193–211.PubMedGoogle Scholar
  51. Wolinsky  E, Rynearson  TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis. 1968;97:1032–7.PubMedGoogle Scholar
  52. Dawson  DJ, Jennis  F. Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum. J Clin Microbiol. 1980;11:190–2.PubMedGoogle Scholar
  53. Kikuchi  K, Bernard  EM, Kiehn  TE, Armstrong  D, Riley  LW. Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum. J Clin Microbiol. 1994;32:1763–7.PubMedGoogle Scholar
  54. Radford  AJ. Mycobacterium ulcerans in Australia. Aust N Z J Med. 1975;5:162–9.PubMedGoogle Scholar
  55. Meyers  WM, Tignokpa  N, Priuli  GB, Portaels  F. Mycobacterium ulcerans infection (Buruli ulcer): first reported patients from Togo. Br J Dermatol. 1996;134:1116–21. DOIPubMedGoogle Scholar
  56. Monson  MH, Gibson  DW, Connor  DH, Kappes  R, Heinz  HA. Mycobacterium ulcerans in Liberia: a clinicopathologic study of 6 patients with Buruli ulcer. Acta Trop. 1984;41:165–72.PubMedGoogle Scholar
  57. Hayman  J. Postulated epidemiology of Mycobacterium ulcerans infection. Int J Epidemiol. 1991;20:1093–8. DOIPubMedGoogle Scholar
  58. Wendt  SL, George  KL, Parker  BC, Gruft  H, Falkinham  JO. Epidemiology of nontuberculous mycobacteria. III. Isolation of potentially pathogenic mycobacteria in aerosols. Am Rev Respir Dis. 1980;122:259–63.PubMedGoogle Scholar
  59. McOrist  S, Jerrett  IV, Anderson  M, Hayman  J. Cutaneous and respiratory tract infection with Mycobacterium ulcerans in two koalas (Phascolarctos cinereus). J Wildl Dis. 1985;21:171–3.PubMedGoogle Scholar
  60. Gluckman  SJ. Mycobacterium marinum. Clin Dermatol. 1995;13:273–6. DOIPubMedGoogle Scholar
  61. Aronson  JD. Spontaneous tuberculosis in salt water fish. Infect Dis. 1926;39:315–20.
  62. Collins  CH, Grange  JM, Noble  WC, Yates  MD. Mycobacterium marinum infections in man. Journal of Hygiene (Cambodia). 1985;94:135–49. DOIGoogle Scholar
  63. McClain  EH. Case study: mariner's TB. American Association of Occupational Health Nurses Journal. 1989;37:329–32.
  64. Flowers  DJ. Human infection due to Mycobacterium marinum after a dolphin bite. Journal of Clinical Pediatrics. 1970;23:475–7.

Main Article

Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external